Vertical transmission of histoplasmosis associated with anti-tumor necrosis factor therapy

James G. Carlucci; Natasha Halasa; C. Buddy Creech; Daniel E. Dulek; Oscar G. Gómez-Duarte; George E. Nelson; H. Keipp Talbot; Melissa L. Scalise; Patricia L. Scott; Uma Mahadevan; Dawn B. Beaulieu

doi:10.1093/jpids/piw001

Vertical transmission of histoplasmosis associated with anti-tumor necrosis factor therapy

James G. Carlucci
, Natasha Halasa
, C. Buddy Creech
, Daniel E. Dulek
, Oscar G. Gómez-Duarte
, George E. Nelson
, H. Keipp Talbot
, Melissa L. Scalise
, Patricia L. Scott
, Uma Mahadevan
, Dawn B. Beaulieu

Department of Epidemiology and Environmental Health

Vanderbilt University
Tennessee Maternal Fetal Medicine
University of California at San Francisco

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Therapeutics blocking the activity of tumor necrosis factor (anti-TNF) are a risk factor for invasive fungal infections; however, infectious risks to infants born to mothers receiving anti-TNF therapy are not well defined. We report a case of vertical transmission of disseminated histoplasmosis in a mother-infant pair exposed to anti- TNF therapy.

Original language	English
Article number	piw001
Pages (from-to)	e9-e12
Journal	Journal of the Pediatric Infectious Diseases Society
Volume	5
Issue number	2
DOIs	https://doi.org/10.1093/jpids/piw001
State	Published - Jun 10 2016

Keywords

Histoplasmosis
Immunocompromised host
Infant
Tumor necrosis factor
Vertical transmission

Access to Document

10.1093/jpids/piw001

Cite this

Carlucci, J. G., Halasa, N., Buddy Creech, C., Dulek, D. E., Gómez-Duarte, O. G., Nelson, G. E., Keipp Talbot, H., Scalise, M. L., Scott, P. L., Mahadevan, U., & Beaulieu, D. B. (2016). Vertical transmission of histoplasmosis associated with anti-tumor necrosis factor therapy. Journal of the Pediatric Infectious Diseases Society, 5(2), e9-e12. Article piw001. https://doi.org/10.1093/jpids/piw001

@article{fa08b42e44d0493f9a3de2ccc0179012,

title = "Vertical transmission of histoplasmosis associated with anti-tumor necrosis factor therapy",

abstract = "Therapeutics blocking the activity of tumor necrosis factor (anti-TNF) are a risk factor for invasive fungal infections; however, infectious risks to infants born to mothers receiving anti-TNF therapy are not well defined. We report a case of vertical transmission of disseminated histoplasmosis in a mother-infant pair exposed to anti- TNF therapy.",

keywords = "Histoplasmosis, Immunocompromised host, Infant, Tumor necrosis factor, Vertical transmission",

author = "Carlucci, \{James G.\} and Natasha Halasa and \{Buddy Creech\}, C. and Dulek, \{Daniel E.\} and G{\'o}mez-Duarte, \{Oscar G.\} and Nelson, \{George E.\} and \{Keipp Talbot\}, H. and Scalise, \{Melissa L.\} and Scott, \{Patricia L.\} and Uma Mahadevan and Beaulieu, \{Dawn B.\}",

note = "Publisher Copyright: {\textcopyright} The Author 2015.",

year = "2016",

month = jun,

day = "10",

doi = "10.1093/jpids/piw001",

language = "English",

volume = "5",

pages = "e9--e12",

journal = "Journal of the Pediatric Infectious Diseases Society",

issn = "2048-7193",

publisher = "Oxford University Press",

number = "2",

}

Carlucci, JG, Halasa, N, Buddy Creech, C, Dulek, DE, Gómez-Duarte, OG, Nelson, GE, Keipp Talbot, H, Scalise, ML, Scott, PL, Mahadevan, U & Beaulieu, DB 2016, 'Vertical transmission of histoplasmosis associated with anti-tumor necrosis factor therapy', Journal of the Pediatric Infectious Diseases Society, vol. 5, no. 2, piw001, pp. e9-e12. https://doi.org/10.1093/jpids/piw001

TY - JOUR

T1 - Vertical transmission of histoplasmosis associated with anti-tumor necrosis factor therapy

AU - Carlucci, James G.

AU - Halasa, Natasha

AU - Buddy Creech, C.

AU - Dulek, Daniel E.

AU - Gómez-Duarte, Oscar G.

AU - Nelson, George E.

AU - Keipp Talbot, H.

AU - Scalise, Melissa L.

AU - Scott, Patricia L.

AU - Mahadevan, Uma

AU - Beaulieu, Dawn B.

N1 - Publisher Copyright: © The Author 2015.

PY - 2016/6/10

Y1 - 2016/6/10

N2 - Therapeutics blocking the activity of tumor necrosis factor (anti-TNF) are a risk factor for invasive fungal infections; however, infectious risks to infants born to mothers receiving anti-TNF therapy are not well defined. We report a case of vertical transmission of disseminated histoplasmosis in a mother-infant pair exposed to anti- TNF therapy.

AB - Therapeutics blocking the activity of tumor necrosis factor (anti-TNF) are a risk factor for invasive fungal infections; however, infectious risks to infants born to mothers receiving anti-TNF therapy are not well defined. We report a case of vertical transmission of disseminated histoplasmosis in a mother-infant pair exposed to anti- TNF therapy.

KW - Histoplasmosis

KW - Immunocompromised host

KW - Infant

KW - Tumor necrosis factor

KW - Vertical transmission

UR - https://www.scopus.com/pages/publications/85006223144

U2 - 10.1093/jpids/piw001

DO - 10.1093/jpids/piw001

M3 - Article

C2 - 27012275

AN - SCOPUS:85006223144

SN - 2048-7193

VL - 5

SP - e9-e12

JO - Journal of the Pediatric Infectious Diseases Society

JF - Journal of the Pediatric Infectious Diseases Society

IS - 2

M1 - piw001

ER -

Vertical transmission of histoplasmosis associated with anti-tumor necrosis factor therapy

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this